Estimate potential savings with Leukomed® Sorbact®

Click on the sliding scales to adjust the parameters.

Number of caesarean sections per period

Current incidence of SSI

Using Sorbact®

2.5%

Average cost of an SSI

The cost of dressings (to protect and prevent infection) is not included in the calculation. It is often a very small part of the total.

Select currency

Standard dressing
Leukomed® Sorbact®

total number of SSIs

less SSIs

A relative SSI risk reduction of 65 % is expected when using Sorbact®

Standard dressing
Leukomed® Sorbact®

total cost

cost savings for SSIs

A relative SSI risk reduction of 65 % is expected when using Sorbact®

Disclaimer: This value calculator is for illustrative purposes only. Any savings will vary depending on the hospital’s practices, internal routines and procedures, type of patients and the quality of efforts made locally.

A relative SSI risk reduction of 65 % is expected when using Sorbact® 1


1.Stanirowski PJ, Bizoń M, et al. 2016. Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section. Surg Infect (Larchmt). 17(4):427-435link

Number of caesarean sections per period

Number of caesarean sections. A period is often a year for a hospital, region or country.

Current incidence of SSI

The incidence rate (the % of new SSIs within a time period) following a caesarean section vary between 3%-15%.1


1.Saeed KBM, Greene RA, et al. 2017. Incidence of surgical site infection following caesarean section: a systematic review and meta-analysis protocol. BMJ Open. 7:e013037. link

Average cost of an SSI

Average cost for treating an SSI is approximately 4400€ at 2017 prices.1,2 The main cost driver is extra length of stay in hospital. Approximate additional costs attributable to SSI vary between 900€-7300€ depending on the type of surgery and the severity of the infection.3

Total cost of SSIs = number of SSIs x average cost of an SSI


1.Jenks PJ, Laurent M, et al. 2014. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J Hosp Infect. 86(1):24-33.link

2.Stanirowski PJ, Davies H, et al. 2019. Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section. J Wound Care. 28(4):222-228.link

3.Leaper DJ, Van Goor H, et al. 2004. Surgical site infection – a European perspective of incidence and economic burden. Int Wound J. 1(4):247-273.link